FDA Opens Genetic Floodgates with 23andMe Decision - MIT Technology Review

MIT Technology Review
FDA Opens Genetic Floodgates with 23andMe Decision
MIT Technology Review
Gene-testing companies will be able to directly tell consumers their risk for certain diseases. by Emily Mullin; April 6, 2017. 23andMe can now sell spit-based genetic tests that estimate a person's health risk for certain diseases directly to ...
FDA allows marketing of first direct-to-consumer tests that provide genetic risk information for certain conditionsFDA.gov
2013 > 23andMe, Inc. 11/22/13